SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies - Quaterly Results

24 Jan 2023 Evaluate
The revenue zoomed 11.43% to Rs. 3986.40 millions for the quarter ended December 2022 as compared to Rs. 3577.60 millions during the corresponding quarter last year.Net profit declined -15.47% to Rs. 278.70 millions from Rs. 329.70 millions.Operating Profit reported a sharp decline to 620.20 millions from 735.60 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3986.40 3577.60 11.43 12392.30 11308.40 9.58 15397.20 12403.00 24.14
Other Income 3.70 1.60 131.25 18.40 20.30 -9.36 23.20 31.20 -25.64
PBIDT 620.20 735.60 -15.69 2225.50 2485.60 -10.46 3293.20 2266.90 45.27
Interest 70.10 38.10 83.99 163.90 111.00 47.66 141.40 222.20 -36.36
PBDT 550.10 697.50 -21.13 2061.60 2374.60 -13.18 3151.80 2044.70 54.14
Depreciation 171.60 192.20 -10.72 529.10 609.10 -13.13 789.50 731.20 7.97
PBT 378.50 505.30 -25.09 1532.50 1765.50 -13.20 2362.30 1313.50 79.85
TAX 99.80 175.60 -43.17 372.70 624.00 -40.27 817.10 389.60 109.73
Deferred Tax 17.70 18.40 -3.80 -55.80 -70.00 -20.29 -115.20 4.90 -2451.02
PAT 278.70 329.70 -15.47 1159.80 1141.50 1.60 1545.20 923.90 67.25
Equity 184.30 184.30 0.00 184.30 184.30 0.00 184.30 184.30 0.00
PBIDTM(%) 15.56 20.56 -24.33 17.96 21.98 -18.30 21.39 18.28 17.02

Indoco Remedies Share Price

228.20 -23.05 (-9.17%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×